Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

McLaren Proton Therapy System

K-Number: K160063 · 2016-02-25

Decision Date2016-02-25
Product CodeLHN
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

McLaren Proton Therapy System is the device name listed in this FDA 510(k) record. The listed applicant is Mclaren Health Care Corporation. It received FDA 510(k) clearance on 2016-02-25 under 510(k) number K160063. The device is classified under product code LHN. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the McLaren Proton Therapy System?

McLaren Proton Therapy System is a medical device that received FDA 510(k) clearance on 2016-02-25. The listed applicant is Mclaren Health Care Corporation. The 510(k) number is K160063.

When did McLaren Proton Therapy System receive FDA 510(k) clearance?

McLaren Proton Therapy System received FDA 510(k) clearance on 2016-02-25, under 510(k) number K160063.

Who is the listed applicant for McLaren Proton Therapy System?

The FDA 510(k) record lists Mclaren Health Care Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for McLaren Proton Therapy System?

The FDA product code for McLaren Proton Therapy System is LHN.

Related Devices (Code: LHN)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.